Filing Details
- Accession Number:
- 0001493152-21-006314
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-18 14:08:34
- Reporting Period:
- 2021-03-16
- Accepted Time:
- 2021-03-18 14:08:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
772320 | Gene Biotherapeutics Inc. | CRXM | Biological Products, (No Disgnostic Substances) (2836) | 840635673 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1741021 | J Christopher Jemapete | 6888 S. Irvington Court Aurora CO 80016 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-16 | 300,000 | $0.04 | 3,800,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-03-17 | 200,000 | $0.40 | 4,000,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price for two transactions effected on March 16, 2021, with purchase prices per share ranging from $0.0378 to $0.04. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- Represents the weighted average purchase price for 16 transactions effected on March 17, 2021, with purchase prices per share ranging from $0.0378 to $0.0425. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.